声触诊弹性成像无创评估肾纤维化与慢性肾病进展:诊断准确性及组织病理学相关性
本研究纳入按eGFR分期的CKD患者,在肾活检前用声触诊弹性成像(STE)测量肾皮质弹性,以病理IFTA分级为参考标准。STE各参数随CKD分期进展而升高(P<.001);STEmean鉴别晚期与早期CKD的AUC为0.90,以12.7 kPa为阈值时敏感度70.5%、特异度92.7%。STE值随IFTA严重程度升高,鉴别轻与中重度IFTA的AUC为0.81,鉴别轻中度与重度IFTA的AUC为0.79。
要点
- STEmean鉴别晚期与早期CKD的AUC为0.90,阈值12.7 kPa时敏感度70.5%、特异度92.7%。
- STE值随IFTA严重程度升高:轻度11.31±2.42 kPa、中度13.85±3.65 kPa、重度15.3±3.19 kPa(P<.001)。
- STE对CKD分期的诊断效能优于对IFTA分级的诊断效能。
核心结论
- STE是评估CKD进展和肾小管间质纤维化的可靠超声方法,对CKD分期的诊断效能优于对IFTA分级的诊断效能。
研究设计与样本
- 研究纳入因临床指征行肾活检以诊断和监测CKD的患者,按eGFR分为全部五个CKD分期。
关键影像表现/征象
- STE各弹性参数随CKD分期进展而进行性升高(P<.001)。
- STEmean与eGFR呈负相关(r=-0.75,95%CI:-0.81至-0.66;P<.001)。
- STE值随IFTA严重程度显著升高:轻度IFTA 11.31±2.42 kPa、中度IFTA 13.85±3.65 kPa、重度IFTA 15.3±3.19 kPa(P<.001)。
诊断标准与关键数值
- STEmean鉴别晚期CKD与早期CKD的AUC为0.90(95%CI:0.85-0.95),以12.7 kPa为阈值时敏感度70.5%、特异度92.7%。
- STEmean鉴别轻度IFTA与中重度IFTA的AUC为0.81(95%CI:0.74-0.88)。
- STEmean鉴别轻中度IFTA与重度IFTA的AUC为0.79(95%CI:0.72-0.87)。
临床应用与阅片要点
- STEmean对CKD分期的诊断效能优于肾径线参数。
- STE对CKD分期的诊断效能优于对IFTA分级的诊断效能,提示其无创肾脏评估的潜在临床价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: The aim of this study was to evaluate the clinical utility of sound touch elastography (STE) in assessing renal cortical elasticity across different stages of chronic kidney disease (CKD) and its association with histopathological grading of interstitial fibrosisand tubular atrophy (IFTA).
MATERIALS AND METHODS: All enrolled patients with clinically indicated renal biopsies for the diagnosis and monitoring of CKD, stratified across all five CKD stages based on estimated glomerular filtration rate (eGFR), underwent conventional B-mode ultrasound and STE examinations of the biopsied kidney, performed by an experienced sonographer blinded to clinical and histopathological data, to measure renal cortical elasticity parameters. Histopathological assessment of the biopsy samples served as the reference standard for IFTA grading.
RESULTS: All STE-derived elasticity parameters demonstrated progressive elevation with advancing CKD stages (P<.001), receiver operating characteristic (ROC) analysis demonstrated STEmean's superior diagnostic performance for advanced CKD vs early-stage CKD (area under the curve [AUC] = 0.90, 95% confidenceinterval [CI]: 0.85-0.95; sensitivity 70.5%, specificity: 92.7% at 12.7 kPa), outperforming renal dimensional parameters and inversely correlating with eGFR (r=-0.75, 95% CI: -0.81 to -0.66; P<.001). Similarly, STE values increased significantly with IFTA severity: mild IFTA (11.31 ± 2.42 kPa), moderate IFTA (13.85 ± 3.65 kPa), and severe IFTA (15.3 ± 3.19 kPa) (P<.001). STEmean demonstrated high accuracy in differentiating IFTA severity, with AUCs of 0.81 (95% CI: 0.74-0.88) for d0iscriminating mild from moderate to severe IFTA and 0.79 (95% CI: 0.72-0.87) for distinguishing mild to moderate from severe IFTA.
CONCLUSION: STE represents a reliable ultrasound-based method for evaluating CKD progression and tubulointerstitial fibrosis. The technique shows better diagnostic performance for CKD staging than for IFTA grading, suggesting its potential clinical utility in noninvasive renal assessment.
引用
- Ge XY, Lan ZK, Huang WJ, et al. Sound touch elastography for noninvasive assessment of renal fibrosis and chronic kidney disease progression: diagnostic accuracy and histopathological correlation. Clin Radiol. 2025. PMID: 41264990. doi:10.1016/j.crad.2025.107145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。